You are here: Home » PTI Stories » National » News
Business Standard

Shield Healthcare acquires two entities for undisclosed sum

Topics
Health Medical Pharma

Press Trust of India  |  Chennai 

City-based pharmaceutical firm Shield Healthcare has acquired two companies -- Brio Bliss Life Science and a Bengaluru-based Nutri Synapzz Therapeutics for an "undisclosed sum."

Following the acquisitions, Shield Healthcare aims to increase its presence in gynaecology and paediatrics, a company release said here on Thursday.

City-based Brio Bliss Life Science focuses on developmental paediatrics segment while Nutri Synapzz caters to IVF specialities.

Shield Healthcare said pharmaceuticals and healthcare focused private equity firm, Fulcrum Venture would also hold significant stake post the acquisitions of the two companies.

"At Shield, we started our journey 25 years back catering to general practitioners and physicians. The footprint has been increased from Tamil Nadu to Andhra Pradesh and to other parts of South India. Realising the shift in market, we zeroed in on gynaecology and infertility segments..", Shield Healthcare Founder-Managing Director L Mahadevan said.

He said the company recently inducted Aniruddha Rajurkar as its Chief Executive Officer.

Commenting on the acquisitions, Rajurkar said "We will drive the synergy benefits of the merger for improved market leadership. We will bring out technologically superior formulations to effectively address health issues in women and children.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, October 03 2019. 15:15 IST
RECOMMENDED FOR YOU